Kerala Ayurveda (KERALAYUR) | Financial Analysis & Statements
Kerala Ayurveda Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
286.1M
Gross Profit
216.4M
75.65%
Operating Income
-58.4M
-20.40%
Net Income
20.3M
7.09%
EPS (Diluted)
₹1.89
Balance Sheet Metrics
Total Assets
1.3B
Total Liabilities
1.4B
Shareholders Equity
-99.6M
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Kerala Ayurveda Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.2B | 1.1B | 930.5M | 800.0M | 618.7M |
| Cost of Goods Sold | 249.7M | 224.3M | 203.8M | 175.3M | 153.3M |
| Gross Profit | 942.0M | 850.1M | 726.7M | 624.7M | 465.4M |
| Gross Margin % | 79.0% | 79.1% | 78.1% | 78.1% | 75.2% |
| Operating Expenses | |||||
| Research & Development | 1.3M | 7.6M | 3.6M | 1.2M | 750.0K |
| Selling, General & Administrative | 343.3M | 176.5M | 168.9M | 122.0M | 94.7M |
| Other Operating Expenses | 80.5M | 196.9M | 175.6M | 138.8M | 68.1M |
| Total Operating Expenses | 425.1M | 380.9M | 348.1M | 261.9M | 163.6M |
| Operating Income | -99.7M | 71.3M | 50.1M | 98.6M | 43.7M |
| Operating Margin % | -8.4% | 6.6% | 5.4% | 12.3% | 7.1% |
| Non-Operating Items | |||||
| Interest Income | 3.3M | 1.6M | 768.0K | 2.6M | 346.0K |
| Interest Expense | 30.1M | 44.6M | 48.2M | 65.2M | 63.2M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -122.4M | 12.7M | -5.6M | 28.0M | -67.4M |
| Income Tax | 17.2M | 21.3M | -1.3M | 4.1M | -18.9M |
| Effective Tax Rate % | 0.0% | 167.9% | 0.0% | 14.7% | 0.0% |
| Net Income | -139.6M | -8.6M | -4.3M | 23.9M | -48.4M |
| Net Margin % | -11.7% | -0.8% | -0.5% | 3.0% | -7.8% |
| Key Metrics | |||||
| EBITDA | -42.4M | 70.8M | 25.4M | 97.3M | 8.6M |
| EPS (Basic) | ₹-11.60 | ₹-1.38 | ₹-0.85 | ₹2.24 | ₹-4.57 |
| EPS (Diluted) | ₹-11.60 | ₹-1.38 | ₹-0.85 | ₹2.24 | ₹-4.57 |
| Basic Shares Outstanding | 12032000 | 11036000 | 10556000 | 10556000 | 10600000 |
| Diluted Shares Outstanding | 12032000 | 11036000 | 10556000 | 10556000 | 10600000 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Kerala Ayurveda Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 33.9M | 227.9M | 43.8M | 28.7M | 185.6M |
| Short-term Investments | 2.0M | - | - | - | - |
| Accounts Receivable | 193.0M | 158.0M | 129.6M | 133.4M | 103.3M |
| Inventory | 129.6M | 155.0M | 124.9M | 119.7M | 110.0M |
| Other Current Assets | 4.2M | - | 54.2M | 1.0K | -1 |
| Total Current Assets | 407.7M | 600.9M | 352.5M | 371.5M | 436.5M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 10.1M | 239.0M | 9.1M | 9.6M | 9.6M |
| Goodwill | 232.4M | 325.7M | 326.9M | 326.5M | 211.6M |
| Intangible Assets | 82.7M | 120.5M | 121.8M | 121.3M | 6.4M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | -1.0K | 22.5M | 28.7M | 30.2M | 31.6M |
| Total Non-Current Assets | 879.9M | 806.2M | 806.5M | 731.7M | 708.3M |
| Total Assets | 1.3B | 1.4B | 1.2B | 1.1B | 1.1B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 57.9M | 77.7M | 75.0M | 79.0M | 61.3M |
| Short-term Debt | 484.4M | 101.7M | 238.6M | 327.3M | 189.8M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 81.4M | 8.3M | 7.1M | 21.9M | 21.4M |
| Total Current Liabilities | 879.8M | 404.0M | 526.9M | 603.6M | 419.2M |
| Non-Current Liabilities | |||||
| Long-term Debt | 222.2M | 594.2M | 504.2M | 372.1M | 585.0M |
| Deferred Tax Liabilities | - | 1.8M | 0 | 0 | 0 |
| Other Non-Current Liabilities | 228.5M | 5.7M | 3.4M | 2.4M | 3.4M |
| Total Non-Current Liabilities | 507.5M | 651.7M | 553.3M | 420.1M | 673.6M |
| Total Liabilities | 1.4B | 1.1B | 1.1B | 1.0B | 1.1B |
| Equity | |||||
| Common Stock | 120.3M | 120.3M | 105.6M | 105.6M | 105.6M |
| Retained Earnings | - | -186.3M | -170.7M | -165.3M | -192.4M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | -99.6M | 351.3M | 78.8M | 79.4M | 52.0M |
| Key Metrics | |||||
| Total Debt | 706.6M | 695.8M | 742.8M | 699.4M | 774.8M |
| Working Capital | -472.1M | 196.8M | -174.4M | -232.2M | 17.3M |
Balance Sheet Composition
Kerala Ayurveda Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -122.4M | 57.4M | 42.6M | 93.2M | -4.2M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | 62.3M | - | - | - | - |
| Working Capital Changes | 63.0M | -47.9M | 39.5M | -130.5M | 73.0M |
| Operating Cash Flow | 43.7M | 7.8M | 81.4M | -39.8M | 68.5M |
| Investing Activities | |||||
| Capital Expenditures | -133.2M | -10.8M | -61.1M | -28.5M | -10.4M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | 1.0M |
| Investing Cash Flow | -133.2M | -10.8M | -61.1M | -28.5M | -9.4M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | 90.0M | 132.1M | - | 136.4M |
| Debt Repayment | - | - | - | -213.0M | -11.2M |
| Financing Cash Flow | 29.1M | 221.0M | 36.9M | -67.5M | 114.1M |
| Free Cash Flow | -85.0M | 9.2M | 36.8M | -33.5M | 63.9M |
| Net Change in Cash | -60.4M | 218.1M | 57.1M | -135.9M | 173.1M |
Cash Flow Trend
Kerala Ayurveda Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
617.16
Price to Book
39.17
Price to Sales
2.49
PEG Ratio
11.48
Profitability Ratios
Profit Margin
-18.52%
Operating Margin
-8.08%
Return on Equity
140.14%
Return on Assets
-10.84%
Financial Health
Current Ratio
0.47
Debt to Equity
938.32
Beta
0.08
Per Share Data
EPS (TTM)
₹-19.60
Book Value per Share
₹6.23
Revenue per Share
₹105.16
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| KERALAYUR | 3.1B | 617.16 | 39.17 | 140.14% | -18.52% | 938.32 |
| Sun Pharmaceutical | 3.9T | 36.73 | 5.15 | 15.08% | 19.21% | 6.68 |
| Divi's Laboratories | 1.7T | 67.11 | 10.82 | 14.64% | 24.04% | 0.58 |
| Sun Pharma Advanced | 46.7B | -13.65 | -13.55 | 157.88% | -53.22% | -1.21 |
| Innova Captab | 41.4B | 31.20 | 4.05 | 13.37% | 8.85% | 32.95 |
| Gujarat Themis | 35.4B | 73.73 | 13.36 | 19.64% | 29.99% | 27.04 |
Financial data is updated regularly. All figures are in the company's reporting currency.





